WUXI BIOLOGICS-0,0000083 financial statements, including revenue, expenses, profit, and loss
The total revenue of 1FW2 for the last semiannual is 1.07 B EUR, and it's 4.70% lower compared to the previous semiannual. The net income of H2 23 is 141.99 M EUR.